Member Info for Dibs61

Steve - probably

Due a tick up. I can dummy sell above quoted mid @ 4.85 and buy is at full ask 5p now. With the caveat that it’s v small volume of course however MM’s usually revert to marking down.

I don’t see any way they could record an interview that contains any price sensitive information prior to that information being released to the market.

Chunky not sure, volume hasn’t been high and at times it’s felt like there’s been a background buyer. Timelines for announcements have slipped somewhat with both the the FDA and ovarian cancer study were ‘expected’ in H2 2021. That’s clearly not going to happen now. This will be used by some to exit. Watch then come flooding back when they do (assuming positive).

Personally I see a fantastic future for this company and have been using the dip to add to my holdings.

Hope everyone had a great Christmas and I wish all my fellow Xtracters a Happy and Healthy (if not prosperous) New Year. See you all on the other side!

Wiseinvestor23 - ‘ The answer to the first questions suggests the EMG was the major final hurdle - official JV to follow very shortly’

Absolute Tosh and you know it.

Conroy dodged the question in the recent interview when he was asked if the agreement would be signed BEFORE the EGM. So you can be sure it WON’T. The EGM will sign it off, of course it will. But that is ALREADY priced in and is a technicality. Still waiting for their signature into the new year……

That’s 900k sterling. I would say that’s quite low really. My view is that a placing is likely in the next quarter or so and it would also explain the lack of investor interest. But, in typical AIM fashion they’ll do it off the back of a bit of news flow.

TheOutsideView - ‘ potentially large supply. Would you agree?’

Not large supply in the context of the overall shares in issue and broadly matched by demand too or the price would drop more than it has considering the weight of apparent ‘sells’ being printed. MM’s have been ‘happy’ to take plenty of shares at this level so there must be a matching demand at this level or they will be out of pocket.

No Lucky you’re not wrong. I won’t check the maths just now but you are def on the right lines. The best way to verify it is against the market valuation as it was then pre-dilution (@9 or so pence) and the market cap now.

We also have very poor general market sentiment - no Santa rally - indeed prob quite a few small investors shedding a few shares to pay for Christmas.

Like others have said though - hole 36 very positive. Hopefully the penny will start to drop soon.

Ok look at the continued stream of sell trades. No buys to offset. At the same time I can dummy sell 50k @ 1.27 - the current bid price. So we must have a background buyer.

Odd, unusual even to see a SP edge up on AIM on very small trades, v low volume.

It’s almost imperceptibly moved up 20% albeit from a low point.

Virtually nothing but a stream of sell trades in the last few days but price remains relatively firm. So there must be a background buyer(s) or the price would’ve sunk a lot more. I’ve taken the opportunity to add against this price weakness and will do so further if able.

FDA can take their time!

There is clearly a view in the market that further funding will be required. That is the most likely explanation for the disappointing SP reaction to the discovery of a second porphyry system. You could argue that general market sentiment is also currently poor and that could be a contributor. Why could the market take that view (of possible further funding)? Simple, it’s because this (second discovery) is essentially a NEW development and not covered within the overall scope of Phase 2. We are talking about a Phase 3 now. Colin has a conundrum though. He hasn’t had the benefit of a good rise in the SP to get another raise away at a higher price (the last one was 5.6p). So he has to have - he MUST have some good news flow to come in terms of drills and assays.

I might be wrong here but I don’t think so. Things have now changed dramatically, and much for the better I might add - but ‘Ascot’ is a new Beast which cannot be ignored and is not covered under Phase 2.

What does all this mean for investors? More patience I’m afraid if you want to stick around for the pay off. The wildcard is a deal suddenly sprung out of thin air with a major.

It should not be a long wait for first drill results. We are talking shallow targets here - anything between 50 to 300m max. So a few days at most of drilling rather than weeks. Let’s hope the communication is a little better in the next RNS. The recent drilling start announcement, while welcome was also extraordinary in its abruptness and lack of ANY information whatsoever.

Doing what they do best, pulling a few pants down this morning. Low volume compared to recent days but that gives them the opportunity….

It’s worth pointing out this is and remains at least for now a RETAIL stock. Which is why Prof Conroy aims all his interviews to a RETAIL audience. Besides, with 39m shares in issue and sparse liquidity there is no way a large institution could take a position here even if they wanted to. Which, atm with a £13m MC they wouldn’t.

So what we are seeing is growing retail investor interest.

1DAYMAYBE - oh you’re the ‘Strap on’ guy from XTR…… Are you still in XTR? Can’t recall you posting recently

Can anybody try a dummy buy? I still can’t get a price on dummy sell. Normally stocks come out of auction but this seems stuck!

Andrew4444 - superb post. Realistic, balanced, I totally agree that our expectations ‘may’ not be met viz a viz 40p for example but to me it seems impossible that we can lose money from this level.

This drop is purely sentiment driven with v low volume allowing MM’s to drop the price in an attempt to stimulate volume (that’s how they make their money)